Les remboursements de médicaments anti-obésité (QO 006140C).

This parliamentary question seeks information regarding the reimbursement status of medications used to treat obesity. It addresses how the healthcare system manages the cost of these treatments and the criteria used to determine if they are covered by public insurance. The procedure affects patients struggling with obesity and the healthcare providers who prescribe these medications, potentially influencing access to specialized weight-loss treatments in Belgium.